COMMUNIQUÉS West-GlobeNewswire

Real Energy Sustainability Discussed in the Journal of American Physicians and Surgeons

14/06/2018 - 18:13

TUCSON, Ariz., June 14, 2018 (GLOBE NEWSWIRE) -- The drive for energy sustainability is becoming a political weapon to block progress, rather than an inspiration for a steady process of prudent conservation, writes Paul [...]

DIAXONHIT DEVIENT EUROBIO SCIENTIFIC : Changement de nom adopté à l'Assemblée Générale Annuelle

14/06/2018 - 17:46

DIAXONHIT DEVIENT EUROBIO SCIENTIFIC Changement de nom adopté à l'Assemblée Générale Annuelle Les actionnaires ont également adopté toutes les résolutions à titre ordinaire et à titre extraordinaire agréées par le [...]

Solon Eiendom ASA : Primary insider notification

14/06/2018 - 16:43

(Oslo, Norway, 14 June 2018) Reference is made to Solon Eiendom ASA's (the "Company") prospectus dated 16 May 2018 (the "Prospectus") for inter alia the subsequent offering (the "Subsequent Offering") of up to 396,040 [...]

Orion Biotechnology Canada Acquires K2Biomedical

14/06/2018 - 16:28

OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the acquisition of K2Biomedical, a specialty pharmaceutical research company based in Cracow, [...]

Tivity Health Adds Sara J. Finley and Beth M. Jacob to Board of Directors

14/06/2018 - 16:15

NASHVILLE, Tenn., June 14, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ:TVTY) today announced that it has added two new members to its Board of Directors. Sara J. Finley, Principal of Threshold Corporate [...]

Rafael Pharmaceuticals to Present New Data Validating Efficacy and Tolerability of CPI-613 in Treating Acute Myeloid Leukemia at the 23rd Congress of the European Hematology Association

14/06/2018 - 16:12

Newark, NJ, June 14, 2018 (GLOBE NEWSWIRE) -- CPI-613 is Rafael Pharmaceuticals' lead drug candidate, a first-in-class anticancer compound designed to disrupt the altered energy production pathways in cancer cells by [...]

Rexahn Announces Adjournment of Annual Meeting of Shareholders until Wednesday, June 27, 2018

14/06/2018 - 16:00

Three of four proposals pass with shareholder approval Annual Meeting adjourned solely with respect to Proposal 3 – approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase [...]

Sienna Biopharmaceuticals to Present at JMP Securities Life Science Conference

14/06/2018 - 15:05

WESTLAKE VILLAGE, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna [...]

Kane Biotech to Present at The MicroCap Conference in Toronto

14/06/2018 - 14:39

Conference Held June 21 Featuring Attractive Companies Across All Sectors WINNIPEG, Manitoba, June 14, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is [...]

Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound

14/06/2018 - 14:30

SCAN Clinical Trial Results Intended to Support CPT Code Application for Incremental Diagnostic Reimbursement REDWOOD CITY, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of [...]

OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund

14/06/2018 - 14:30

GAITHERSBERG, Md., June 14, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has negotiated modifications related to its $1,000,000 Second Amended and Restated Senior Secured Promissory Note ( [...]

Clinical Genomics Pathology Inc. receives licensure from State of California Department of Public Health

14/06/2018 - 14:30

BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP accredited New Jersey [...]

Agritek Holdings, Inc. Announces Permit Approvals For San Juan, Puerto Rico 15,000 Sq. Ft. Cultivation And Processing Facility As Colorado Hemp Farm Moves Toward Production

14/06/2018 - 14:30

LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS

14/06/2018 - 14:30

COPENHAGEN, Denmark, June 14, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc.’s (OTCQB:VIBI) Vilact skin cream won the buyers choice award at the recent ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS (efficient program [...]

ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States

14/06/2018 - 14:23

EDISON, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures

14/06/2018 - 14:03

SAINT LAURENT, Quebec, June 14, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) announces that it intends to issue 307,070 common shares of the [...]

Evolus to Participate in Two Upcoming Investor Conferences

14/06/2018 - 14:01

IRVINE, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company, announced today that members of management will be participating in two upcoming investor [...]

Foamix Pharmaceuticals to Participate in the Cantor Dermatology & Aesthetics Summit

14/06/2018 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary [...]

Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st

14/06/2018 - 14:00

WALTHAM, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]